1. Home
  2. BLND vs INDV Comparison

BLND vs INDV Comparison

Compare BLND & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blend Labs Inc.

BLND

Blend Labs Inc.

HOLD

Current Price

$1.07

Market Cap

307.5M

Sector

Technology

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$36.02

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLND
INDV
Founded
2012
N/A
Country
United States
United States
Employees
419
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.5M
4.7B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BLND
INDV
Price
$1.07
$36.02
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $4.13
N/A
AVG Volume (30 Days)
★ 1.8M
1.4M
Earning Date
05-07-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
58.33
★ 8100.00
EPS
N/A
★ 1.67
Revenue
$123,585,000.00
★ $1,239,000,000.00
Revenue This Year
$12.62
N/A
Revenue Next Year
$14.00
N/A
P/E Ratio
★ N/A
$21.50
Revenue Growth
N/A
★ 4.29
52 Week Low
$1.08
$22.56
52 Week High
$3.86
$42.81

Technical Indicators

Market Signals
Indicator
BLND
INDV
Relative Strength Index (RSI) 27.47 49.36
Support Level N/A $35.49
Resistance Level $1.60 $36.62
Average True Range (ATR) 0.07 0.88
MACD -0.03 0.31
Stochastic Oscillator 4.81 64.56

Price Performance

Historical Comparison
BLND
INDV

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segment is Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience. The key revenue for the company is generated from the Blend Platform segment. Company has it's assets in united states, India and Mexico regions.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: